No Single Gene Has Been Isolated for Bipolar Disorder or Schizophrenia
There has been no breakthrough isolating "the gene" for bipolar disorder or schizophrenia because these conditions are highly polygenic disorders involving hundreds to thousands of genetic variants, not a single causative gene. The evidence clearly demonstrates that both conditions result from complex interactions among multiple genes, each contributing small effects to overall disease risk 1.
The Reality of Psychiatric Genetics
The current state of genetic research reveals:
Multiple risk genes with small effects: Recent exome sequencing identified AKAP11 as a shared risk gene between schizophrenia and bipolar disorder, but this represents just one of many contributing factors (odds ratio 7.06) 2. This is not "the gene" but rather one piece of a complex puzzle.
Poor predictive performance: Machine learning models attempting to predict these disorders from genetic data show highly variable and often poor discrimination. For bipolar disorder specifically, predictive ability was "consistently lower than for schizophrenia, frequently overlapping with chance (0.482-0.65 AUC)" 1. This demonstrates that even with advanced computational methods analyzing all available genetic data, we cannot reliably predict these conditions from genetics alone.
Shared genetic architecture: The disorders share substantial genetic liability, with multiple genes operating across traditional diagnostic boundaries 3, 4. For example, neuregulin 1 (NRG1) influences susceptibility to both conditions 3.
Recent Genetic Discoveries (Not Breakthroughs)
What scientists have actually achieved:
Identification of multiple risk variants: Studies have identified specific genes like AKAP11 2, NISCH 5, and ZNF804A 6 that increase risk, but none are deterministic or sufficient to cause disease alone.
Understanding polygenic risk: The genetic contribution involves polygenic risk scores combining effects from numerous variants across the genome, not single gene mutations 1.
High risk of bias in studies: The systematic review found "widespread high risk of bias" in genetic prediction studies, with methodological issues limiting the reliability of reported findings 1.
Clinical Implications
The absence of a single causative gene means genetic testing cannot currently diagnose, predict, or guide treatment for bipolar disorder or schizophrenia in clinical practice. The polygenic nature of these conditions, combined with environmental factors, makes them fundamentally different from single-gene disorders like Huntington's disease or cystic fibrosis.
The claim of isolating "the gene" for these conditions is scientifically inaccurate and represents a misunderstanding of psychiatric genetics. These are complex, multifactorial disorders where genetic risk is distributed across the genome in ways we are still working to understand.